HK1019737A1 - Benzoxazinone dopamine d4 receptor antagonists - Google Patents

Benzoxazinone dopamine d4 receptor antagonists

Info

Publication number: HK1019737A1
Authority: HK; Hong Kong
Prior art keywords: benzoxazinone; dopamine; receptor antagonists; antagonists; receptor
Prior art date: 1996-05-29

Application number

HK99104867A

Other languages

English (en)

Inventor

Thomas Belliotti

Lawrence David Wise

David Juergen Wustrow

Original Assignee

Warner Lambert Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-05-29

Filing date

1999-10-28

Publication date

2000-02-25

1999-10-28 Application filed by Warner Lambert Co filed Critical Warner Lambert Co

2000-02-25 Publication of HK1019737A1 publication Critical patent/HK1019737A1/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Public Health (AREA)
Biomedical Technology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Plural Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

HK99104867A 1996-05-29 1999-10-28 Benzoxazinone dopamine d4 receptor antagonists HK1019737A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US1838396P	1996-05-29	1996-05-29
US4020897P	1997-03-06	1997-03-06
PCT/US1997/008524 WO1997045419A1 (en)	1996-05-29	1997-05-20	Benzoxazinone dopamine d4 receptor antagonists

Publications (1)

Publication Number	Publication Date
HK1019737A1 true HK1019737A1 (en)	2000-02-25

Family

ID=26691052

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK99104867A HK1019737A1 (en)	1996-05-29	1999-10-28	Benzoxazinone dopamine d4 receptor antagonists

Country Status (37)

Country	Link
EP (1)	EP0906294B1 (id)
JP (1)	JP2000511534A (id)
KR (1)	KR20000016151A (id)
CN (1)	CN1074764C (id)
AR (1)	AR008372A1 (id)
AT (1)	ATE231846T1 (id)
AU (1)	AU731104B2 (id)
BG (1)	BG64049B1 (id)
BR (1)	BR9709630A (id)
CA (1)	CA2253406A1 (id)
CO (1)	CO4940505A1 (id)
CZ (1)	CZ384698A3 (id)
DE (1)	DE69718786T2 (id)
DK (1)	DK0906294T3 (id)
EA (1)	EA001486B1 (id)
EE (1)	EE03686B1 (id)
ES (1)	ES2191180T3 (id)
GE (1)	GEP20012389B (id)
HK (1)	HK1019737A1 (id)
HN (1)	HN1997000075A (id)
HR (1)	HRP970301B1 (id)
HU (1)	HUP9903758A3 (id)
ID (1)	ID17266A (id)
IL (1)	IL126895A (id)
NO (1)	NO312296B1 (id)
NZ (1)	NZ332737A (id)
PA (1)	PA8431101A1 (id)
PE (1)	PE69398A1 (id)
PL (1)	PL330195A1 (id)
PT (1)	PT906294E (id)
RO (1)	RO120845B1 (id)
SI (1)	SI0906294T1 (id)
SK (1)	SK282703B6 (id)
SV (1)	SV1997000047A (id)
TW (1)	TW542833B (id)
UY (1)	UY24569A1 (id)
WO (1)	WO1997045419A1 (id)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6177422B1 (en)	1996-05-29	2001-01-23	Warner-Lambert Company	Benzoxazinone dopamine D4 receptor antagonists
GB9801392D0 (en) *	1998-01-22	1998-03-18	Smithkline Beecham Plc	Novel compounds
US6177566B1 (en)	1998-06-30	2001-01-23	Neurogen Corporation	6-(4-arylalkylpiperazin-1-yl) benzodioxane and 6-(4-arylalkylpiperazin-1-yl) chromane derivatives: dopamine receptor subtype specific ligands
WO2000000489A2 (en) *	1998-06-30	2000-01-06	Neurogen Corporation	6-(4-arylalkylpiperazin-1-yl)benzodioxane and 6-(4-arylalkylpiperazin-1-yl)chromane derivatives: dopamine receptor subtype specific ligands
US6291463B1 (en)	1998-06-30	2001-09-18	Neurogen Corporation	1-(Benzothiazol-2-yl)-4-(1-phenylmethyl) piperazines: dopamine receptor subtype specific ligands
JP2002519346A (ja) *	1998-06-30	2002-07-02	ニューロゲンコーポレイション	１−（ベンゾチアゾール−２−イル）−４−（１−フェニルメチル）ピペラジン：ドーパミン受容体サブタイプ特異リガンド
DE19844291A1 (de) *	1998-09-18	2000-03-23	Schering Ag	Benzoxazin- und Benzothiazin-Derivate und deren Verwendung in Arzneimitteln
GB9912411D0 (en)	1999-05-28	1999-07-28	Pfizer Ltd	Compounds useful in therapy
MXPA03003820A (es)	2000-10-26	2003-07-28	Smithkline Beecham Plc	Derivados de benzoxazinona, su preparacion y uso.
GB0203804D0 (en)	2002-02-18	2002-04-03	Glaxo Group Ltd	Compounds
GB0209244D0 (en) *	2002-04-23	2002-06-05	Glaxo Group Ltd	Compounds
GB0227240D0 (en) *	2002-11-21	2002-12-31	Glaxo Group Ltd	Compounds
ES2232292B1 (es) *	2003-07-30	2006-11-01	Laboratorios Del Dr. Esteve, S.A.	Compuestos sulfonamidicos derivados de benzoxazinona, su preparacion y uso como medicamentos.
CN100455573C (zh) *	2005-11-11	2009-01-28	华东理工大学	一种制备1,4-苯并噁唑嗪-3-酮化合物的微波合成方法
KR200482995Y1 (ko)	2015-08-19	2017-03-23	이현진	물 공급부를 구비하는 얼음 트레이
EP4328225A1 (en) *	2021-04-23	2024-02-28	Shanghai Hansoh Biomedical Co., Ltd.	Heterocyclic derivative inhibitor and preparation method therefor and application thereof
WO2023178035A1 (en)	2022-03-14	2023-09-21	Slap Pharmaceuticals Llc	Multicyclic compounds
WO2023207283A1 (en) *	2022-04-28	2023-11-02	Ningbo Newbay Technology Development Co., Ltd	Compounds as parp1 inhibitiors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4613598A (en) *	1984-03-13	1986-09-23	Mitsubishi Chemical Industries Limited	Piperazine derivatives and their acid addition salts
EP0233728A1 (en) *	1986-02-11	1987-08-26	Takeda Chemical Industries, Ltd.	1,4-Benzoxazine derivatives their production and use
CA2141791A1 (en) *	1992-08-06	1994-02-17	Geoffrey Stemp	5-(2-oxyphenyl)-pyrrole derivatives as dopamine d3 receptor antagonists

1997
- 1997-05-20 AU AU30727/97A patent/AU731104B2/en not_active Ceased
- 1997-05-20 HU HU9903758A patent/HUP9903758A3/hu unknown
- 1997-05-20 CN CN97195015A patent/CN1074764C/zh not_active Expired - Fee Related
- 1997-05-20 CA CA002253406A patent/CA2253406A1/en not_active Abandoned
- 1997-05-20 RO RO98-01622A patent/RO120845B1/ro unknown
- 1997-05-20 NZ NZ332737A patent/NZ332737A/en unknown
- 1997-05-20 BR BR9709630A patent/BR9709630A/pt not_active Application Discontinuation
- 1997-05-20 SI SI9730482T patent/SI0906294T1/xx unknown
- 1997-05-20 KR KR1019980709719A patent/KR20000016151A/ko not_active Application Discontinuation
- 1997-05-20 GE GEAP19974623A patent/GEP20012389B/en unknown
- 1997-05-20 EE EE9800417A patent/EE03686B1/xx not_active IP Right Cessation
- 1997-05-20 AT AT97925651T patent/ATE231846T1/de not_active IP Right Cessation
- 1997-05-20 PL PL97330195A patent/PL330195A1/xx unknown
- 1997-05-20 JP JP09542647A patent/JP2000511534A/ja not_active Ceased
- 1997-05-20 EA EA199800987A patent/EA001486B1/ru not_active IP Right Cessation
- 1997-05-20 DK DK97925651T patent/DK0906294T3/da active
- 1997-05-20 WO PCT/US1997/008524 patent/WO1997045419A1/en not_active Application Discontinuation
- 1997-05-20 PT PT97925651T patent/PT906294E/pt unknown
- 1997-05-20 DE DE69718786T patent/DE69718786T2/de not_active Expired - Fee Related
- 1997-05-20 CZ CZ983846A patent/CZ384698A3/cs unknown
- 1997-05-20 EP EP97925651A patent/EP0906294B1/en not_active Expired - Lifetime
- 1997-05-20 SK SK1627-98A patent/SK282703B6/sk unknown
- 1997-05-20 IL IL12689597A patent/IL126895A/en not_active IP Right Cessation
- 1997-05-20 ES ES97925651T patent/ES2191180T3/es not_active Expired - Lifetime
- 1997-05-22 HN HN1997000075A patent/HN1997000075A/es unknown
- 1997-05-27 AR ARP970102249A patent/AR008372A1/es unknown
- 1997-05-28 PE PE1997000432A patent/PE69398A1/es not_active Application Discontinuation
- 1997-05-28 ID IDP971778A patent/ID17266A/id unknown
- 1997-05-28 TW TW086107221A patent/TW542833B/zh active
- 1997-05-28 SV SV1997000047A patent/SV1997000047A/es not_active Application Discontinuation
- 1997-05-28 UY UY24569A patent/UY24569A1/es not_active Application Discontinuation
- 1997-05-28 CO CO97029474A patent/CO4940505A1/es unknown
- 1997-05-28 PA PA19978431101A patent/PA8431101A1/es unknown
- 1997-05-29 HR HR970301A patent/HRP970301B1/xx not_active IP Right Cessation
1998
- 1998-11-26 BG BG102959A patent/BG64049B1/bg unknown
- 1998-11-27 NO NO19985531A patent/NO312296B1/no not_active IP Right Cessation
1999
- 1999-10-28 HK HK99104867A patent/HK1019737A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
CO4940505A1 (es)	2000-07-24
HUP9903758A2 (hu)	2000-06-28
DK0906294T3 (da)	2003-05-05
UY24569A1 (es)	2001-08-27
JP2000511534A (ja)	2000-09-05
SK282703B6 (sk)	2002-11-06
ES2191180T3 (es)	2003-09-01
HN1997000075A (es)	1997-07-30
EA199800987A1 (ru)	1999-06-24
HRP970301A2 (en)	1998-04-30
DE69718786D1 (de)	2003-03-06
BG64049B1 (bg)	2003-11-28
HUP9903758A3 (en)	2000-07-28
HRP970301B1 (en)	2002-08-31
PL330195A1 (en)	1999-04-26
CA2253406A1 (en)	1997-12-04
CN1219930A (zh)	1999-06-16
PE69398A1 (es)	1998-12-02
SI0906294T1 (en)	2003-04-30
SV1997000047A (es)	1998-08-13
NO312296B1 (no)	2002-04-22
EE03686B1 (et)	2002-04-15
BG102959A (en)	1999-08-31
AR008372A1 (es)	2000-01-19
IL126895A (en)	2001-06-14
SK162798A3 (en)	1999-06-11
DE69718786T2 (de)	2003-10-23
IL126895A0 (en)	1999-09-22
ID17266A (id)	1997-12-18
CN1074764C (zh)	2001-11-14
NO985531D0 (no)	1998-11-27
CZ384698A3 (cs)	1999-03-17
AU731104B2 (en)	2001-03-22
NO985531L (no)	1998-11-27
TW542833B (en)	2003-07-21
BR9709630A (pt)	1999-08-10
WO1997045419A1 (en)	1997-12-04
PT906294E (pt)	2003-06-30
EA001486B1 (ru)	2001-04-23
PA8431101A1 (es)	2001-12-14
RO120845B1 (ro)	2006-08-30
ATE231846T1 (de)	2003-02-15
AU3072797A (en)	1998-01-05
EP0906294A1 (en)	1999-04-07
EE9800417A (et)	1999-06-15
NZ332737A (en)	2000-06-23
EP0906294B1 (en)	2003-01-29
GEP20012389B (en)	2001-03-25
KR20000016151A (ko)	2000-03-25

Publication	Publication Date	Title
HUP9903445A3 (en)	2002-01-28	2,4-diaminopyrimidine derivates as dopamine d4 receptor antagonists
EP0912175A4 (en)	1999-09-08	FIBRINOGENIC RECEPTOR ANTAGONISTS
HK1019737A1 (en)	2000-02-25	Benzoxazinone dopamine d4 receptor antagonists
ZA975671B (en)	1997-12-29	IL-8 receptor antagonists.
HU9603525D0 (en)	1997-02-28	Vironectin receptor antagonists
ZA974234B (en)	1997-12-11	Adhesion receptor antagonists.
EP0998285A4 (en)	2003-01-08	ANTAGONISTS OF THE ALPHA 1a ADRENERIC RECEPTOR
GB9625843D0 (en)	1997-01-29	Phenyl spiroethercycloalkyl tachykinn receptor antagonists
EP0885205A4 (en)	2002-11-27	FIBRINOGENIC RECEPTOR ANTAGONISTS
ZA977301B (en)	1998-02-16	IL-8 receptor antagonists.
EP0885213A4 (en)	1999-04-28	FIBRINOGEN RECEPTOR ANTAGONISTS
ZA971513B (en)	1998-08-21	Oxa-and thia-diazole muscarinic receptor antagonists
EP1023068A4 (en)	2001-05-16	ALPHA 1a ADRENORE RECEPTOR ANTAGONISTS
AU6230698A (en)	1998-09-18	Dopamine d4 receptor antagonist
EP1014973A4 (en)	2000-09-20	ANTAGONISTS OF ALPHA 1a ADRENORECEPTORS
AU1100300A (en)	2000-04-26	Piperidyloxadiazoles as dopamine receptor antagonists
ZA974684B (en)	1997-12-30	Benzoxazinone dopamine D4 receptor antagonists.
ZA977445B (en)	1998-02-23	Troponyl piperazines as dopamine D4 receptor ligands.
EP0957908A4 (en)	2003-03-12	FIBRINOGENIC RECEPTOR ANTAGONISTS
GB9708766D0 (en)	1997-06-25	Fibrinogen receptor antagonist
GB9613688D0 (en)	1996-08-28	Fibrinogen receptor antagonists
GB9603371D0 (en)	1996-04-17	Fibrinogen receptor antagonists
GB9606489D0 (en)	1996-06-05	Fibrinogen receptor antagonists
GB9603245D0 (en)	1996-04-17	Fibrinogen receptor antagonist
GB9603423D0 (en)	1996-04-17	Alpha la adrenergic receptor antagonists

Legal Events

Date	Code	Title	Description
2004-12-15	PF	Patent in force
2006-12-29	PC	Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)	Effective date: 20060520